An ALKBH3 Inhibitor HUHS199 Suppresses Proliferation of Glioblastoma Cells by Targeting 1‐Methyladenosine on GADD45A mRNA
Glioblastoma (GBM) is a highly aggressive, poor‐prognosis brain tumor classified as WHO grade IV, for which effective treatments remain limited. Although AlkB homolog 3 (ALKBH3), a demethylase for 1‐methyladenosine (m1A) and 3‐methylcytidine (m3C) in DNA and RNA, has been implicated in cancer cell proliferation, its fu...